circRACGAP1 Promotes Non-Small Cell Lung Cancer Proliferation by Regulating miR-144-5p/CDKL1 Signaling Pathway

Expression patterns of circRACGAP1 and miR-144-5p in non-small cell lung cancer tissues and cell lines were quantified by qRT-PCR analysis. Then, the function of circRACGAP1 on cell proliferation and tumorigenesis were confirmed in vitro and in vivo using CCK-8 assay, colony formation, EdU incorporation, and xenograft technique.
[Cancer Gene Therapy]
Abstract

Continue reading “circRACGAP1 Promotes Non-Small Cell Lung Cancer Proliferation by Regulating miR-144-5p/CDKL1 Signaling Pathway”

Bookmark

No account yet? Register

0
Share

Luteolin Enhances TRAIL Sensitivity in Non-Small Cell Lung Cancer Cells through Increasing DR5 Expression and Drp1-Mediated Mitochondrial Fission

Scientists sought to investigate the potential effects of luteolin as a tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) sensitizer in non-small cell lung cancer cells.
[Archives of Biochemistry and Biophysics]
Abstract

Continue reading “Luteolin Enhances TRAIL Sensitivity in Non-Small Cell Lung Cancer Cells through Increasing DR5 Expression and Drp1-Mediated Mitochondrial Fission”

Bookmark

No account yet? Register

0
Share

DMBT1 Is Up‐Regulated in Lung Epithelial Cells after Hypoxia and Changes Surfactant Ultrastructure

Deleted in malignant brain tumors 1 (DMBT1) expression was up‐regulated in human lung tissue after fetal/peri‐/postnatal hypoxia. Additionally, in vitro experiments showed increased DMBT1 RNA expression in A549 cells after hypoxia.
[Pediatric Pulmonology]
Abstract

Continue reading “DMBT1 Is Up‐Regulated in Lung Epithelial Cells after Hypoxia and Changes Surfactant Ultrastructure”

Bookmark

No account yet? Register

0
Share

High Expression of NEK2 Promotes Lung Cancer Progression and Drug Resistance and Is Regulated by Mutant EGFR

Elevated never in mitosis gene A-related kinase 2 level promoted the rapid cell cycle progression and favors the rapid proliferation of epidermal growth factor receptor-mutant non-small cell lung cancer cells.
[Molecular and Cellular Biochemistry]
Abstract

Continue reading “High Expression of NEK2 Promotes Lung Cancer Progression and Drug Resistance and Is Regulated by Mutant EGFR”

Bookmark

No account yet? Register

0
Share

DRP1 Promotes Lactate Utilization in KRAS‐Mutant Non‐Small Cell Lung Cancer Cells

Scientists developed a lactate‐dependent cell proliferation assay and found that dynamin‐related protein (DRP1), which was highly expressed in KRAS‐mutant non‐small cell lung cancer (NSCLC), was required for tumor cells to proliferate and uses lactate as fuel, demonstrating the critical role of DRP1 in the metabolic reprogramming of NSCLC.
[Cancer Science]
Abstract

Continue reading “DRP1 Promotes Lactate Utilization in KRAS‐Mutant Non‐Small Cell Lung Cancer Cells”

Bookmark

No account yet? Register

0
Share

Complement and Tissue Factor-Enriched Neutrophil Extracellular Traps Are Key Drivers in COVID-19 Immunothrombosis

The authors investigated how complement interacted with the platelet/neutrophil extracellular traps (NETS)/thrombin axis, using COVID-19 specimens, cell-based inhibition studies and NETs/human aortic endothelial cell co-cultures.
[Journal of Clinical Investigation]
Skendros, P., Mitsios, A., Chrysanthopoulou, A., Mastellos, D. C., Metallidis, S., Rafailidis, P., Ntinopoulou, M., Sertaridou, E., Tsironidou, V., Tsigalou, C., Tektonidou, M. G., Konstantinidis, T., Papagoras, C., Mitroulis, I., Germanidis, G., Lambris, J. D., & Ritis, K. (2020). Complement and tissue factor-enriched neutrophil extracellular traps are key drivers in COVID-19 immunothrombosis. The Journal of Clinical Investigation. https://doi.org/10.1172/JCI141374 Cite
Abstract

Continue reading “Complement and Tissue Factor-Enriched Neutrophil Extracellular Traps Are Key Drivers in COVID-19 Immunothrombosis”

Bookmark

No account yet? Register

0
Share

Inhibition of Mitophagy Drives Macrophage Activation and Anti-bacterial Defense during Sepsis

Scientists showed that lipopolysaccharide in combination with IFNγ, inhibited PINK1-dependent mitophagy in macrophages through a STAT1-dependent activation of the inflammatory caspases 1 and 11.
[Journal of Clinical Investigation]
Patoli, D., Mignotte, F., Deckert, V., Dusuel, A., Dumont, A., Rieu, A., Jalil, A., Dongen, K. V., Bourgeois, T., Gautier, T., Magnani, C., Guern, N. L., Mandard, S., Bastin, J., Djouadi, F., Schaeffer, C., Guillaumot, N., Narce, M., Nguyen, M., … Thomas, C. (2020). Inhibition of mitophagy drives macrophage activation and anti-bacterial defense during sepsis. The Journal of Clinical Investigation. https://doi.org/10.1172/JCI130996 Cite
AbstractFull Article

Continue reading “Inhibition of Mitophagy Drives Macrophage Activation and Anti-bacterial Defense during Sepsis”

Bookmark

No account yet? Register

0
Share

Immune-Mobilizing Monoclonal T Cell Receptors Mediate Specific and Rapid Elimination of Hepatitis B-Infected Cells

The ability of immune mobilizing monoclonal T cell receptors Against Virus-envelope to activate and redirect polyclonal T cells towards cells containing integrated HBV and cells infected with hepatitis B virus was assessed using cytokine secretion assays and imaging‐based killing assays.
[Hepatology]
Fergusson, J. R., Wallace, Z., Connolly, M. M., Woon, A. P., Suckling, R. J., Hine, D. W., Barber, C., Bunjobpol, W., Choi, B.-S., Crespillo, S., Dembek, M., Dieckmann, N., Donoso, J., Godinho, L. F., Grant, T., Howe, D., McCully, M. L., Perot, C., Sarkar, A., … Knox, A. (n.d.). Immune-mobilising monoclonal T cell receptors mediate specific and rapid elimination of Hepatitis B-infected cells. Hepatology, n/a(n/a). https://doi.org/10.1002/hep.31503 Cite
Abstract

Continue reading “Immune-Mobilizing Monoclonal T Cell Receptors Mediate Specific and Rapid Elimination of Hepatitis B-Infected Cells”

Bookmark

No account yet? Register

0
Share

Cerebrospinal Fluid Features in SARS-CoV-2 RT-PCR Positive Patients

Scientists observed neither SARS-CoV-2 RNA in the cerebrospinal fluid, nor intrathecal IgG synthesis, but did observe signs of blood-brain barrier disruption.
[Clinical infectious Diseases]
Bellon, M., Schweblin, C., Lambeng, N., Cherpillod, P., Vazquez, J., Lalive, P. H., Schibler, M., & Deffert, C. (n.d.). Cerebrospinal fluid features in SARS-CoV-2 RT-PCR positive patients. Clinical Infectious Diseases. https://doi.org/10.1093/cid/ciaa1165 Cite
AbstractFull Article

Continue reading “Cerebrospinal Fluid Features in SARS-CoV-2 RT-PCR Positive Patients”

Bookmark

No account yet? Register

0
Share

Neutrophil Extracellular Traps Amplify Neutrophil Recruitment and Inflammation in Neutrophilic Asthma by Stimulating the Airway Epithelial Cells to Activate the TLR4/NF-κB Pathway and Secrete Chemokines

Formation of neutrophil extracellular traps (NETs) and neutrophil swarming was seen in a mouse model of neutrophilic asthma. Additionally, NETs were found to stimulate airway cells to express CXCL1, CXCL2, and CXCL8 via the TLR4/NF-κB pathway, which recruits neutrophils to the inflammation site.
[Aging]
Aging | Neutrophil extracellular traps amplify neutrophil recruitment and inflammation in neutrophilic asthma by stimulating the airway epithelial cells to activate the TLR4/ NF-κB pathway and secrete chemokines - Full Text. (n.d.). Retrieved August 7, 2020, from https://www.aging-us.com/article/5f2427ad6c2ca900075aeb68/text Cite
Full Article

Continue reading “Neutrophil Extracellular Traps Amplify Neutrophil Recruitment and Inflammation in Neutrophilic Asthma by Stimulating the Airway Epithelial Cells to Activate the TLR4/NF-κB Pathway and Secrete Chemokines”

Bookmark

No account yet? Register

0
Share

Inhibitory Effect of MicroRNA-608 on Lung Cancer Cell Proliferation, Migration, and Invasion by Targeting BRD4 through the JAK2/STAT3 Pathway

Investigators determined the fundamental mechanism of microRNA-608 in the development of lung cancer.
[Bosnian Journal of Basic Medical Sciences]
Abstract

Continue reading “Inhibitory Effect of MicroRNA-608 on Lung Cancer Cell Proliferation, Migration, and Invasion by Targeting BRD4 through the JAK2/STAT3 Pathway”

Bookmark

No account yet? Register

0
Share

Daiichi Sankyo Announces Clinical Trial Collaboration with AstraZeneca to Evaluate Patritumab Deruxtecan (U3-1402) in Combination with TAGRISSO in EGFR-Mutated Non-Small Cell Lung Cancer

Daiichi Sankyo Company, Limited announced that it has entered into a clinical trial collaboration with AstraZeneca to evaluate the combination of patritumab deruxtecan, a HER3 directed DXd antibody drug conjugate, and TAGRISSO, an epidermal growth factor receptor tyrosine kinase inhibitor, in patients with EGFR-mutated advanced or metastatic non-small cell lung cancer.
[Daiichi Sankyo Company, Limited]
Press Release

Continue reading “Daiichi Sankyo Announces Clinical Trial Collaboration with AstraZeneca to Evaluate Patritumab Deruxtecan (U3-1402) in Combination with TAGRISSO in EGFR-Mutated Non-Small Cell Lung Cancer”

Bookmark

No account yet? Register

0
Share
Share